Why the study?
Diabetes self-management is complicated by high rates of depression and stress, and whether a multicondition digital therapeutic platform improves glycemic management in this population was unknown.
Does a multicondition digital therapeutic platform improve blood glucose levels in high-risk diabetes patients with comorbid depression and stress?
Does a multicondition digital therapeutic platform improve blood glucose levels in high-risk diabetes patients with comorbid depression and stress?
The use of a multicondition digital therapeutic platform was associated with significant reductions in average blood glucose and high glucose events over one year in high-risk diabetes patients with comorbid depression and stress.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for multicondition digital therapeutics in T2D with mental health comorbidity; randomized trials needed before practice change.
HERSHCOVITZ et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: